South Korea Diabetes Drugs Market Share

Market Share of South Korea Diabetes Drugs Industry

The South Korea Diabetes Drugs Market is moderately consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones.

South Korea Diabetes Drugs Market Leaders

1. AstraZeneca

2. Boehringer Ingelheim

3. Eli Lilly and Company

4. Novo Nordisk A/S

5. Sanofi Aventis

*Disclaimer: Major Players sorted in no particular order